Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer’s Disease
Michele Rossi, Michela Freschi, Luciana de Camargo Nascente, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 4972-4990
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
Priscila Baltazar Gonçalves, Ana Carolina Rennó Sodero, Yraima Cordeiro
Biomolecules (2021) Vol. 11, Iss. 5, pp. 767-767
Open Access | Times Cited: 70
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 43
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
Sandra Codony, Caterina Pont, Christian Griñán‐Ferré, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 4909-4925
Open Access | Times Cited: 37
Tacrine-Based Hybrids: Past, Present, and Future
Anna Bubley, Alexander S. Erofeev, Peter Gorelkin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1717-1717
Open Access | Times Cited: 22
Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults
Francesco Samarelli, Rosa Purgatorio, Gianfranco Lopopolo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116353-116353
Open Access | Times Cited: 9
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 9
Multi-targeted benzylpiperidine–isatin hybrids: Design, synthesis, biological and in silico evaluation as monoamine oxidases and acetylcholinesterase inhibitors for neurodegenerative disease therapies
Nikita Negi, Senthil Raja Ayyannan, Rati Kailash Prasad Tripathi
Journal of Computer-Aided Molecular Design (2025) Vol. 39, Iss. 1
Closed Access
Pivotal role of nitrogen heterocycles in Alzheimer’s disease drug discovery
Shikha Kumari, Maddeboina Krishnaiah, Rinda Devi Bachu, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103322-103322
Open Access | Times Cited: 35
Design, Characterization, Molecular Docking, and Insecticidal Activity of Some New Heterocyclic Compounds Containing Pyrazole Moiety against Spodoptera frugiperda (J.E. Smith) (Noctuidae: Lepidoptera)
M. S. A. El‐Gaby, Mohamed Hussein, Mohamed Ahmed Mahmoud Abdel Reheim, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 3, pp. 917-933
Closed Access | Times Cited: 6
Combining Experimental and Computational Methods to Produce Conjugates of Anticholinesterase and Antioxidant Pharmacophores with Linker Chemistries Affecting Biological Activities Related to Treatment of Alzheimer’s Disease
Галина Ф. Махаева, N. V. Kovaleva, Елена В. Рудакова, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 321-321
Open Access | Times Cited: 5
In Vitro and In Vivo Investigations of Chromone Derivatives as Potential Multitarget-Directed Ligands: Cognitive Amelioration Utilizing a Scopolamine-Induced Zebrafish Model
Naveen Kumar, Kailash Jangid, Vishal Kumar, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 14, pp. 2565-2585
Closed Access | Times Cited: 5
Multi-target-directed therapeutic strategies for Alzheimer’s disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition
Jeasang Yoo, Jimin Lee, Byeongha Ahn, et al.
Chemical Science (2025)
Open Access
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Antioxidant Compounds in the Treatment of Alzheimer’s Disease: Natural, Hybrid, and Synthetic Products
Maryam Hatami, Mojtaba Mortazavi, Zahra Baseri, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 13
Metal‐Free Synthesis via Intramolecular Cyclization, Enzyme Inhibition Properties and Molecular Docking of Novel Isoindolinones
Ufuk Atmaca, Rüya Sağlamtaş, Yusuf Sert, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Closed Access | Times Cited: 13
Design, Synthesis, and Pharmacological Evaluation of Embelin–Aryl/alkyl Amine Hybrids as Orally Bioavailable Blood–Brain Barrier Permeable Multitargeted Agents with Therapeutic Potential in Alzheimer’s Disease: Discovery of SB-1448
Vijay K. Nuthakki, Sushil Choudhary, Chilakala Nagarjuna Reddy, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 6, pp. 1193-1219
Closed Access | Times Cited: 12
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases
Çiğdem Şahin, Lilia Magomedova, Thais A. M. Ferreira, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 1961-1978
Open Access | Times Cited: 18
Discovery of quinazolin-4(3H)-one derivatives as novel AChE inhibitors with anti-inflammatory activities
Ling Lv, Mireguli Maimaitiming, Yan Huang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115346-115346
Closed Access | Times Cited: 11
Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease
Elisa Uliassi, Christian Bergamini, Nicola Rizzardi, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 91, pp. 117419-117419
Open Access | Times Cited: 10
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo
Claudia Mugnaini, Antonella Brizzi, Marco Paolino, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 5, pp. 955-971
Closed Access | Times Cited: 3
Phloroglucinol Derivatives Exert Anti‐Inflammatory Effects and Attenuate Cognitive Impairment in LPS‐Induced Mouse Model
Jushin Kim, Ji Won Choi, Hyeon Jeong Kim, et al.
ChemMedChem (2024) Vol. 19, Iss. 17
Open Access | Times Cited: 3
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117829-117829
Open Access | Times Cited: 3
Design, Synthesis, and Biological Evaluation of Imidazolylacetophenone Oxime Derivatives as Novel Brain-Penetrant Agents for Alzheimer’s Disease Treatment
Zhao-Yuan Bian, Peng‐Xiao Li, Xu-Yao Feng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116794-116794
Closed Access | Times Cited: 3
Butyrylcholinesterase inhibitors as potential anti-Alzheimer’s agents: an updated patent review (2018-present)
José G. Fernández‐Bolaños, Óscar López
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 8, pp. 913-932
Closed Access | Times Cited: 17
Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer’s Diseases: Emerging Paradigms and Strategies
Narayanaperumal Pravin, Krzysztof Jóźwiak
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6085-6085
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top